Navigation Links
Statement from Lighthouse International About the Study on Gene Therapy Concerning Leber's Congenital Amaurosis

NEW YORK, April 29 /PRNewswire/ -- Lighthouse International is a leader in vision healthcare -- serving people who are visually impaired and partially sighted for 103 years.

According to Dr. Tara A Cortes, President and CEO of Lighthouse International:

"This is a dramatic breakthrough in gene therapy that could potentially impact other genetic eye diseases that affect children."

According to Yocasta Urena, 28, an employee of Lighthouse International who has Leber's Congenital Amaurosis and whose 4-year-old daughter has the same condition, "This research is a ray of hope for me and certainly for my daughter's future." Her daughter, Aolani Cruz, has been in the Lighthouse International Child Development Center (which educates children who are visually impaired and sighted) for a year and a half and has made significant progress.

Dr. Cortes continued, "In the decades to come, this therapy may also have implications for other serious eye diseases such as Age Related Macular Degeneration, which has been found to have a genetic link and affects some 9 million Americans and millions abroad.

There is a vision loss epidemic in the United States which affects millions. Research and vision rehabilitation & services will also be needed to address this growing national health problem."

Founded in 1905, Lighthouse International is a leading non-profit organization dedicated to preserving vision and providing critically needed health care services to help people of all ages overcome the challenges of vision loss. Through services, education, research and advocacy, the Lighthouse enables people with low vision and blindness to enjoy safe, independent and productive lives. For more information about vision loss, its causes and what you can do about it, contact Lighthouse International at 1-800-829-0500 or visit

SOURCE Lighthouse International
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. VaxGen Files 2006 Financial Statements and Provides Cash Update
2. ARYx Therapeutics, Inc. Files Registration Statement for Initial Public Offering
3. Anacor Files Registration Statement for Initial Public Offering
4. IsoTis Files Definitive Proxy Statement
5. MAKO Surgical Corp. Files Registration Statement for Initial Public Offering of Common Stock
6. Statement on Direct-To-Consumer Genetic Testing
7. Coherent Announces Restatement Related to Stock-Based Compensation
8. XTL Biopharmaceuticals: AGM/EGM Statements
9. Statement from GPhA President and CEO Kathleen Jaeger on FDAs Generic Initiative
10. Symmetry Medical Discloses Accounting Issues at Sheffield, UK Operating Unit and Possible Restatement
11. CCPM Issues Statement on FDAs GIVE Initiative
Post Your Comments:
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 system ... experiments and avoiding the use of exogenous expression plasmids. The simplicity of programming ... systematic gain-of-function studies. , This complement to loss-of-function studies, such as with ...
(Date:10/11/2017)... , Oct. 11, 2017  VMS BioMarketing, a leading provider ... nationwide oncology Clinical Nurse Educator (CNE) network, which will launch ... for communication among health care professionals to enhance the patient ... office staff, and other health care professionals to help women ... cancer. ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh ... orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of ... SBT-100 is able to cross the cell membrane and bind intracellular STAT3 and ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... Dr. Bob ... at his local San Diego Rotary Club. The event entitled “Stem ... CA and had 300+ attendees. Dr. Harman, DVM, MPVM was joined by two ...
Breaking Biology Technology:
(Date:6/23/2017)... ITHACA, N.Y. , June 23, 2017 ... a leader in dairy research, today announced a new ... help reduce the chances that the global milk supply ... this dairy project, Cornell University has become the newest ... Food Supply Chain, a food safety initiative that includes ...
(Date:5/16/2017)... 16, 2017  Veratad Technologies, LLC ( ), ... and identity verification solutions, announced today they will participate ... May 15 thru May 17, 2017, in ... Trade Center. Identity impacts the lives ... today,s quickly evolving digital world, defining identity is critical ...
(Date:4/24/2017)... Janice Kephart , former 9/11 ... Partners, LLP (IdSP) , today issues the following ... March 6, 2017 Executive Order: Protecting the ... be instilled with greater confidence, enabling the reactivation ... applications are suspended by until at least July ...
Breaking Biology News(10 mins):